Nona Biosciences and MedUni Vienna Collaborate on Infectious Diseases
CAMBRIDGE, Massachusetts, July 23, 2026 Nona Biosciences has announced a strategic research collaboration with the Medical University of Vienna...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CAMBRIDGE, Massachusetts, July 23, 2026 Nona Biosciences has announced a strategic research collaboration with the Medical University of Vienna...
CAMBRIDGE, Massachusetts, July 1, 2026 Nona Biosciences has entered into a strategic collaboration with Lonza to develop a next-generation...
Cambridge, MA – December 3, 2025: Nona Biosciences has appointed Dr. Hongjiang Miao as its first Chief AI Officer,...
